Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$36,563,246
+$5,540,791 QoQ
Shares Held
233,303
+14.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
10.18%
of 13F equity value
Holder Rank
#77
of 1,603 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 2%
Shared 8%
None 90%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Promethos Capital, LLC holds $36,848,901 across 2 Drug Manufacturers - General names. NVS ranks #1 (99.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
This page
|
233,303 | $36,563,246 | |
| 2 | MRK |
Merck & Co., Inc.
|
2,223 | $285,655 |
All Filings in NVS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,563,246 | 233,303 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $31,022,455 | 203,093 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $30,993,727 | 224,804 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $26,568,763 | 207,180 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $23,909,760 | 197,585 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $20,918,664 | 187,645 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,188,923 | 156,088 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $16,226,561 | 141,076 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $15,018,950 | 141,076 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $10,841,982 | 112,085 | Shares | Sole | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||